Determinants of Patient’s Global Assessment of Disease Activity and Physician’s Global Assessment of Disease Activity in patients with rheumatoid arthritis: A post hoc analysis of overall and Japanese results from phase 3 clinical trials

References

• Tobon GJ, Youinou P, Saraux A. The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. J Autoimmun. 2010;35:10–14.
   PubMed Web of Science ®Google Scholar
• Yamanaka H, Sugiyama N, Inoue E, Taniguchi A, Momohara S. Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I). Mod Rheumatol. 2014;24:33–40.
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Kuwana M, Kondo H, Takeuchi T. Discordance in global assessments between patient and estimator in patients with newly diagnosed rheumatoid arthritis: associations with progressive joint destruction and functional impairment. J Rheumatol. 2014;41:1061–6.
   PubMed Web of Science ®Google Scholar
• Barton JL, Imboden J, Graf J, Glidden D, Yelin EH, Schillinger D. Patient–physician discordance in assessments of global disease severity in rheumatoid arthritis. Arthritis Care Res. 2010;62:857–64.
   PubMed Web of Science ®Google Scholar
• Cho SK, Sung YK, Choi CB, Bang SY, Cha HS, Choe JY, et al. What factors affect discordance between physicians and patients in the global assessment of disease activity in rheumatoid arthritis? Mod Rheumatol. 2017;27:35–41.
   PubMed Web of Science ®Google Scholar
• Egholm CL, Krogh NS, Pincus T, Dreyer L, Ellingsen T, Glintborg B, et al. Discordance of global assessments by patient and physician is higher in female than in male patients regardless of the physician’s sex: data on patients with rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis from the DANBIO registry. J Rheumatol. 2015;42:1781–5.
   PubMed Web of Science ®Google Scholar
• Khan NA, Spencer HJ, Abda E, Aggarwal A, Alten R, Ancuta C, et al. Determinants of discordance in patients' and physicians' rating of rheumatoid arthritis disease activity. Arthritis Care Res. 2012;64:206–14.
   PubMed Web of Science ®Google Scholar
• Nicolau G, Yogui MM, Vallochi TL, Gianini RJ, Laurindo IM, Novaes GS. Sources of discrepancy in patient and physician global assessments of rheumatoid arthritis disease activity. J Rheumatol. 2004;31:1293–6.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Strand V, Koenig AS, Szumski A, Kotak S, Jones TV. Discordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivity. Arthritis Res Ther. 2016;18:114.
   PubMed Web of Science ®Google Scholar
• Hobbs KF, Cohen MD. Rheumatoid arthritis disease measurement: a new old idea. Rheumatology. 2012;51(Suppl6):vi21–7.
   Google Scholar
• Desthieux C, Hermet A, Granger B, Fautrel B, Gossec L. Patient–physician discordance in global assessment in rheumatoid arthritis: a systematic literature review with meta-analysis. Arthritis Care Res. 2016;68:1767–73.
   PubMed Web of Science ®Google Scholar
• Furu M, Hashimoto M, Ito H, Fujii T, Terao C, Yamakawa N, et al. Discordance and accordance between patient's and physician's assessments in rheumatoid arthritis. Scand J Rheumatol. 2014;43:291–5.
   PubMed Web of Science ®Google Scholar
• Markenson JA, Koenig AS, Feng JY, Chaudhari S, Zack DJ, Collier D, et al. Comparison of physician and patient global assessments over time in patients with rheumatoid arthritis: a retrospective analysis from the RADIUS cohort. J Clin Rheumatol. 2013;19:317–23.
   PubMed Web of Science ®Google Scholar
• Studenic P, Radner H, Smolen JS, Aletaha D. Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity. Arthritis Rheum. 2012;64:2814–23.
   PubMed Web of Science ®Google Scholar
• Taylor PC, Keystone EC, van der Heijde D, Weinblatt ME, Del Carmen Morales L, Reyes Gonzaga J, et al. Baricitinib versus placebo or adalimumab in rheumatoid arthritis. N Engl J Med. 2017;376:652–62.
   PubMed Web of Science ®Google Scholar
• Fleischmann R, Schiff M, van der Heijde D, Ramos-Remus C, Spindler A, Stanislav M, et al. Baricitinib, methotrexate, or combination in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment. Arthritis Rheumatol. 2017;69:506–17.
   PubMed Web of Science ®Google Scholar
• Ishiguro N, Dougados M, Cai Z, Zhu B, Ishida M, Sato M, et al. Relationship between disease activity and patient-reported outcomes in rheumatoid arthritis: Post hoc analyses of overall and Japanese results from two phase 3 clinical trials. Mod Rheumatol. 2017. [Epub ahead of print]. doi: 10.1080/14397595.2017.1422232
   Web of Science ®Google Scholar
• Wen H, Ralph Schumacher H, Li X, Gu J, Ma L, Wei H, et al. Comparison of expectations of physicians and patients with rheumatoid arthritis for rheumatology clinic visits: a pilot, multicenter, international study. Int J Rheum Dis. 2012;15:380–9.
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Koike T, Oda H, Yamamoto K, Miyasaka N, Harigai M, et al. Obstacles to the implementation of the treat-to-target strategy for rheumatoid arthritis in clinical practice in Japan. Mod Rheumatol. 2015;25:43–9.
   PubMed Web of Science ®Google Scholar
• Hirsh JM, Boyle DJ, Collier DH, Oxenfeld AJ, Caplan L. Health literacy predicts the discrepancy between patient and provider global assessments of rheumatoid arthritis activity at a public urban rheumatology clinic. J Rheumatol. 2010;37:961–6.
   PubMed Web of Science ®Google Scholar
• Nikiphorou E, Radner H, Chatzidionysiou K, Desthieux C, Zabalan C, van Eijk-Hustings Y, et al. Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature. Arthritis Res Ther. 2016;18:251.
   PubMed Web of Science ®Google Scholar